Phase 4CompletedAge-related condition
This Study Uses Ultrasound to Determine Whether Atorvastatin or Pravastatin Effects the Progression of Coronary Plaque.
A Prospective, Randomized, Double-Blind, Multi-Center Study Comparing the Effects of Atorvastatin Versus Pravastatin on the Progression and Quantification of Coronary Atherosclerotic Lesions as Measured by Intravascular Ultrasound (REVERSAL)
- Sponsor
- Pfizer (Industry)
- Enrollment
- 600 planned
- Conditions
- Coronary Arteriosclerosis
- Interventions
- Atorvastatin; Pravastatin
- Ages
- adults, older adults
- Registry
- NCT00380939
Full record on ClinicalTrials.gov
From the registry
This study was designed to assess the effects on coronary artery plaque using aggressive lipid-lowering therapy versus moderate lipid-lowering therapy. A substudy will examine the effect of these treatments on brachial artery vasoactivity.
Primary outcomes
- The primary efficacy parameter is the percent change in total plaque volume for all slices of anatomically comparable segments of the target coronary artery from baseline to month 18.
- The primary efficacy parameter for brachial artery vasoactivity is the nominal change (month 3 - baseline) in the percent arterial diameter change.
History
Last registry update
Registered
Study completion
Started